Completed NA INTERVENTIONAL 2-arm NCT02724410

Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis

Home Intravenous Versus Oral Antibiotics Following Appendectomy for Perforated Appendicitis in Children, a Randomized Controlled Trial

Sponsor: Wake Forest University Health Sciences

Conditions Perforated Appendicitis

Interventions home intravenous ertapenem home oral amoxicillin-clavulanate peripheral inserted central Catheter

Updated 9 times since 2017 Last updated: Apr 20, 2022 Started: Jan 31, 2011 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02724410, this NA trial focuses on Perforated Appendicitis and remains completed. Sponsored by Wake Forest University Health Sciences, it has been updated 9 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA
May 2022 — Jun 2022 [monthly]

Completed NA
Apr 2022 — May 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wake Forest University Health Sciences

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.